BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem. 1999;263:605-611. [PMID: 10469123 DOI: 10.1046/j.1432-1327.1999.00542.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun W, Zhang DD, Guo L, Wang Q. Expression and significance of hypoxia-inducible factor-1α and its regulator phosphatase and tensin homolog deleted in chromosome 10 in gastric cancer. Shijie Huaren Xiaohua Zazhi 2007; 15(26): 2847-2851 [DOI: 10.11569/wcjd.v15.i26.2847] [Reference Citation Analysis]
2 Iiizumi M, Bandyopadhyay S, Pai SK, Watabe M, Hirota S, Hosobe S, Tsukada T, Miura K, Saito K, Furuta E. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res. 2008;68:7613-7620. [PMID: 18794150 DOI: 10.1158/0008-5472.can-07-6700] [Cited by in Crossref: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
3 Stefanska B, Salamé P, Bednarek A, Fabianowska-Majewska K. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012;107:781-790. [PMID: 21801466 DOI: 10.1017/s0007114511003631] [Cited by in Crossref: 71] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
4 Levy-Nissenbaum O, Sagi-Assif O, Raanani P, Avigdor A, Ben-Bassat I, Witz IP. Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia. Cancer Lett 2003;199:185-92. [PMID: 12969791 DOI: 10.1016/s0304-3835(03)00352-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Koenig A, Bianco SR, Fosmire S, Wojcieszyn J, Modiano JF. Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma. Vet Pathol 2002;39:458-72. [DOI: 10.1354/vp.39-4-458] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
6 Zhu Y, Hoell P, Ahlemeyer B, Sure U, Bertalanffy H, Krieglstein J. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem Int 2007;50:507-16. [PMID: 17169462 DOI: 10.1016/j.neuint.2006.10.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
7 Galetic I, Maira S, Andjelkovic M, Hemmings BA. Negative Regulation of ERK and Elk by Protein Kinase B Modulates c-fos Transcription. Journal of Biological Chemistry 2003;278:4416-23. [DOI: 10.1074/jbc.m210578200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
8 Pollock PM, Walker GJ, Glendening JM, Que Noy T, Bloch NC, Fountain JW, Hayward NK. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines: . Melanoma Research 2002;12:565-75. [DOI: 10.1097/00008390-200212000-00006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
9 Huang YC, Yu HS, Chai CY. Roles of oxidative stress and the ERK1/2, PTEN and p70S6K signaling pathways in arsenite-induced autophagy. Toxicol Lett 2015;239:172-81. [PMID: 26432159 DOI: 10.1016/j.toxlet.2015.09.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
10 Berrie CP. Phosphoinositide 3-kinase inhibition in cancer treatment. Expert Opinion on Investigational Drugs 2005;10:1085-98. [DOI: 10.1517/13543784.10.6.1085] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
11 Yang L, Kuang LG, Zheng HC, Li JY, Wu DY, Zhang SM, Xin Y, Chen Y, Yang S. PTEN encoding product: A marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003; 9(1): 35-39 [PMID: 12508347 DOI: 10.3748/wjg.v9.i1.35] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
12 Berrie CP, Falasca M. Patterns within protein/polyphosphoinositide interactions provide specific targets for therapeutic intervention. FASEB J 2000;14:2618-22. [PMID: 11099481 DOI: 10.1096/fj.00-0096hyp] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int. 2003;53:659-666. [PMID: 14516315 DOI: 10.1046/j.1440-1827.2003.01542.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
14 Depowski PL, Rosenthal SI, Ross JS. Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer. Mod Pathol 2001;14:672-6. [DOI: 10.1038/modpathol.3880371] [Cited by in Crossref: 190] [Cited by in F6Publishing: 186] [Article Influence: 9.0] [Reference Citation Analysis]
15 Ali A, Mishra PK, Sharma S, Arora A, Saluja SS. Effects of PTEN gene alteration in patients with gallbladder cancer. Cancer Genet. 2015;208:587-594. [PMID: 26586294 DOI: 10.1016/j.cancergen.2015.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
16 Elge S, Brearley C, Xia HJ, Kehr J, Xue HW, Mueller-Roeber B. An Arabidopsis inositol phospholipid kinase strongly expressed in procambial cells: synthesis of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 in insect cells by 5-phosphorylation of precursors. Plant J 2001;26:561-71. [PMID: 11489170 DOI: 10.1046/j.1365-313x.2001.01051.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
17 Zhang DD, Guo L, Wang Q. Relationship among PTEN, matrix metalloproteinase-9, and Caspase-3 Expression in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2006; 14(15): 1487-1492 [DOI: 10.11569/wcjd.v14.i15.1487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Rowinsky EK. Signal Events: Cell Signal Transduction and Its Inhibition in Cancer. The Oncologist 2003;8:5-17. [DOI: 10.1634/theoncologist.8-suppl_3-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
19 Hoshino Y, Nishimura K, Sumpio BE. Phosphatase PTEN is inactivated in bovine aortic endothelial cells exposed to cyclic strain. J Cell Biochem 2007;100:515-26. [DOI: 10.1002/jcb.21085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
20 Deng H, Wu RL, Zhou HY, Huang X, Chen Y, Liu LJ. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer. World J Gastroenterol 2006; 12(7): 1013-1017 [PMID: 16534839 DOI: 10.3748/wjg.v12.i7.1013] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
21 Mahimainathan L, Choudhury GG. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem. 2004;279:15258-15268. [PMID: 14718524 DOI: 10.1074/jbc.m314328200] [Cited by in Crossref: 85] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
22 Barnett SF, Defeo-Jones D, Fu S, Hancock PJ, Haskell KM, Jones RE, Kahana JA, Kral AM, Leander K, Lee LL, Malinowski J, McAvoy EM, Nahas DD, Robinson RG, Huber HE. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem J 2005;385:399-408. [PMID: 15456405 DOI: 10.1042/BJ20041140] [Cited by in Crossref: 298] [Cited by in F6Publishing: 157] [Article Influence: 17.5] [Reference Citation Analysis]
23 Lee YJ, Kang SJ, Kim BM, Kim YJ, Woo HD, Chung HW. Cytotoxicity of honeybee (Apis mellifera) venom in normal human lymphocytes and HL-60 cells. Chemico-Biological Interactions 2007;169:189-97. [DOI: 10.1016/j.cbi.2007.06.036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
24 Wang M, Vogel I, Kalthoff H. Correlation between metastatic potential and variants from colorectal tumor cell line HT-29. World J Gastroenterol 2003; 9(11): 2627-2631 [PMID: 14606113 DOI: 10.3748/wjg.v9.i11.2627] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
25 Guo J, Zhu T, Xiao ZX, Chen CY. Modulation of intracellular signaling pathways to induce apoptosis in prostate cancer cells. J Biol Chem 2007;282:24364-72. [PMID: 17573344 DOI: 10.1074/jbc.M702938200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Sriraksa R, Zeller C, El-Bahrawy MA, Dai W, Daduang J, Jearanaikoon P, Chau-In S, Brown R, Limpaiboon T. CpG-island methylation study of liver fluke-related cholangiocarcinoma. Br J Cancer. 2011;104:1313-1318. [PMID: 21448164 DOI: 10.1038/bjc.2011.102] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
27 Badary DM, Abdel-Wanis ME, Hafez MZ, Aboulhagag NA. Immunohistochemical analysis of PTEN, HER2/neu, and ki67 expression in patients with gastric cancer and their association with survival. Pathophysiology 2017;24:99-106. [PMID: 28262306 DOI: 10.1016/j.pathophys.2017.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
28 Yoshimoto M, Cunha IW, Coudry RA, Fonseca FP, Torres CH, Soares FA, Squire JA. FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. Br J Cancer 2007;97:678-85. [PMID: 17700571 DOI: 10.1038/sj.bjc.6603924] [Cited by in Crossref: 209] [Cited by in F6Publishing: 191] [Article Influence: 13.9] [Reference Citation Analysis]
29 Yoshimoto M, Joshua AM, Cunha IW, Coudry RA, Fonseca FP, Ludkovski O, Zielenska M, Soares FA, Squire JA. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol 2008;21:1451-60. [PMID: 18500259 DOI: 10.1038/modpathol.2008.96] [Cited by in Crossref: 212] [Cited by in F6Publishing: 193] [Article Influence: 15.1] [Reference Citation Analysis]
30 Hulleman E, Helin K. Molecular mechanisms in gliomagenesis. Adv Cancer Res 2005;94:1-27. [PMID: 16095998 DOI: 10.1016/S0065-230X(05)94001-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
31 Latta E, Chapman WB. PTEN mutations and evolving concepts in endometrial neoplasia: . Current Opinion in Obstetrics and Gynecology 2002;14:59-65. [DOI: 10.1097/00001703-200202000-00010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
32 Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN. The role of mTOR in the management of solid tumors: an overview. Cancer Treat Rev 2009;35:148-59. [PMID: 19013721 DOI: 10.1016/j.ctrv.2008.09.006] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
33 Bhalla R, Kunju LP, Tomlins SA, Christopherson K, Cortez C, Carskadon S, Siddiqui J, Park K, Mosquera JM, Pestano GA, Rubin MA, Chinnaiyan AM, Palanisamy N. Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Mod Pathol 2013;26:835-48. [PMID: 23348902 DOI: 10.1038/modpathol.2012.234] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
34 Fan JZ, Wang GF, Cheng XB, Dong ZH, Chen X, Deng YJ, Song X. Relationship between mismatch repair protein, RAS, BRAF, PIK3CA gene expression and clinicopathological characteristics in elderly colorectal cancer patients. World J Clin Cases 2021; 9(11): 2458-2468 [PMID: 33889611 DOI: 10.12998/wjcc.v9.i11.2458] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Yang L. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. WJG 2003;9:35. [DOI: 10.3748/wjg.v9.i1.35] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Besson A, Yong VW. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 2001;51:245-64. [PMID: 11407596 DOI: 10.1023/a:1010657030494] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
37 Schöndorf T, Becker M, Göhring U, Wappenschmidt B, Kolhagen H, Kurbacher CM. Interaction of cisplatin, paclitaxel and adriamycin with the tumor suppressor PTEN: . Anti-Cancer Drugs 2001;12:797-800. [DOI: 10.1097/00001813-200111000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
38 Mita MM, Mita A, Rowinsky EK. Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer. Clinical Breast Cancer 2003;4:126-37. [DOI: 10.3816/cbc.2003.n.018] [Cited by in Crossref: 91] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
39 Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W, Zhou T, Li YC, Huang X. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer. World J Gastroenterol 2004; 10(21): 3225-3229 [PMID: 15457582 DOI: 10.3748/wjg.v10.i21.3225] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
40 Di Maira G, Salvi M, Arrigoni G, Marin O, Sarno S, Brustolon F, Pinna LA, Ruzzene M. Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ 2005;12:668-77. [PMID: 15818404 DOI: 10.1038/sj.cdd.4401604] [Cited by in Crossref: 219] [Cited by in F6Publishing: 209] [Article Influence: 12.9] [Reference Citation Analysis]
41 Prasad N, Topping RS, Decker SJ. SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 2001;21:1416-28. [PMID: 11158326 DOI: 10.1128/MCB.21.4.1416-1428.2001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
42 Lowes LE, Allan AL. Recent advances in the molecular characterization of circulating tumor cells. Cancers (Basel). 2014;6:595-624. [PMID: 24633084 DOI: 10.3390/cancers6010595] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
43 Greenspon J, Li R, Xiao L, Rao JN, Marasa BS, Strauch ED, Wang JY, Turner DJ. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. Dig Dis Sci 2009;54:499-510. [PMID: 18654850 DOI: 10.1007/s10620-008-0393-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
44 Hlobilkova A, Guldberg P, Thullberg M, Zeuthen J, Lukas J, Bartek J. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res 2000;256:571-7. [PMID: 10772829 DOI: 10.1006/excr.2000.4867] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
45 Kuramochi H, Nakamura A, Nakajima G, Kaneko Y, Araida T, Yamamoto M, Hayashi K. PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study. BMC Cancer 2016;16:366. [PMID: 27296289 DOI: 10.1186/s12885-016-2400-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
46 Shan X, Czar MJ, Bunnell SC, Liu P, Liu Y, Schwartzberg PL, Wange RL. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol Cell Biol 2000;20:6945-57. [PMID: 10958690 DOI: 10.1128/MCB.20.18.6945-6957.2000] [Cited by in Crossref: 246] [Cited by in F6Publishing: 94] [Article Influence: 11.2] [Reference Citation Analysis]
47 Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW, Li J. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol. 2012;264:13-22. [PMID: 22841775 DOI: 10.1016/j.taap.2012.06.022] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 8.7] [Reference Citation Analysis]
48 Bayani J, Squire JA. Application and interpretation of FISH in biomarker studies. Cancer Letters 2007;249:97-109. [DOI: 10.1016/j.canlet.2006.12.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
49 Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A, Demirhan B. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Int J Gynecol Cancer 2006;16:1412-8. [DOI: 10.1111/j.1525-1438.2006.00541.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
50 Hidalgo M, Rowinsky EK. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 2000;19:6680-6686. [PMID: 11426655 DOI: 10.1038/sj.onc.1204091] [Cited by in Crossref: 424] [Cited by in F6Publishing: 380] [Article Influence: 20.2] [Reference Citation Analysis]
51 Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 2004;24:3526-35. [PMID: 15060171 DOI: 10.1128/MCB.24.8.3526-3535.2004] [Cited by in Crossref: 80] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
52 Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson J, Ross JS. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Annals of Diagnostic Pathology 2004;8:6-16. [DOI: 10.1016/j.anndiagpath.2003.11.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
53 Schöndorf T, Göhring U, Roth G, Middel I, Becker M, Moser N, Valter MM, Hoopmann M. Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients: PTEN expression in ovarian cancer. European Journal of Clinical Investigation 2003;33:256-60. [DOI: 10.1046/j.1365-2362.2003.01116.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
54 Fan C, Quan R, Feng X, Gillis A, He L, Matsumoto ED, Salama S, Cutz JC, Kapoor A, Tang D. ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochim Biophys Acta. 2006;1763:1090-1097. [PMID: 16997395 DOI: 10.1016/j.bbamcr.2006.08.026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
55 Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis. FEBS J. 2014;281:88-103. [PMID: 24138392 DOI: 10.1111/febs.12574] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
56 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
57 Haws ME, Jaramillo TC, Espinosa F, Widman AJ, Stuber GD, Sparta DR, Tye KM, Russo SJ, Parada LF, Stavarache M, Kaplitt M, Bonci A, Powell CM. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J Comp Neurol 2014;522:1171-90. [PMID: 24264880 DOI: 10.1002/cne.23488] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
58 Mohiuddin I, Cao X, Ozvaran MK, Zumstein L, Chada S, Smythe WR. Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation. Annals of Surgical Oncology 2002;9:310-6. [DOI: 10.1007/bf02573071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
59 Zhong X, Zheng JZ, Reed E, Jiang B. SU5416 inhibited VEGF and HIF-1α expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochemical and Biophysical Research Communications 2004;324:471-80. [DOI: 10.1016/j.bbrc.2004.09.082] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
60 Haier J, Nicolson GL. PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 2002;21:1450-60. [PMID: 11857088 DOI: 10.1038/sj.onc.1205213] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
61 Hadad SM, Fleming S, Thompson AM. Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol 2008;67:1-7. [PMID: 18343152 DOI: 10.1016/j.critrevonc.2008.01.007] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
62 Yoshimoto M, Cutz JC, Nuin PA, Joshua AM, Bayani J, Evans AJ, Zielenska M, Squire JA. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 2006;169:128-37. [PMID: 16938570 DOI: 10.1016/j.cancergencyto.2006.04.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 7.9] [Reference Citation Analysis]
63 Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. Journal of Cell Science 2001;114:2375-82. [DOI: 10.1242/jcs.114.13.2375] [Cited by in Crossref: 136] [Cited by in F6Publishing: 95] [Article Influence: 6.5] [Reference Citation Analysis]
64 Yu F, Lu Z, Chen B, Dong P, Zheng J. Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis. Mediators Inflamm 2016;2016:9856538. [PMID: 27610008 DOI: 10.1155/2016/9856538] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
65 Panwalkar A, Verstovsek S, Giles FJ. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer. 2004;100:657-666. [PMID: 14770419 DOI: 10.1002/cncr.20026] [Cited by in Crossref: 154] [Cited by in F6Publishing: 149] [Article Influence: 8.6] [Reference Citation Analysis]
66 Song K, Cornelius SC, Reiss M, Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 2003;278:38342-51. [PMID: 12876289 DOI: 10.1074/jbc.M304583200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
67 He Y, Bai J, Liu P, Dong J, Tang Y, Zhou J, Han P, Xing J, Chen Y, Yu X. miR-494 protects pancreatic β-cell function by targeting PTEN in gestational diabetes mellitus. EXCLI J 2017;16:1297-307. [PMID: 29333131 DOI: 10.17179/excli2017-491] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
68 Zhu Y, Wloch A, Wu Q, Peters C, Pagenstecher A, Bertalanffy H, Sure U. Involvement of PTEN promoter methylation in cerebral cavernous malformations. Stroke 2009;40:820-6. [PMID: 19118244 DOI: 10.1161/STROKEAHA.108.526376] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
69 N.y.cheung A. Molecular targets in gynaecological cancers. Pathology 2007;39:26-45. [DOI: 10.1080/00313020601153273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
70 Gupta A, Dey CS. PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance. Mol Biol Cell. 2012;23:3882-3898. [PMID: 22875989 DOI: 10.1091/mbc.E12-05-0337] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
71 Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys. 2004;429:123-133. [PMID: 15313215 DOI: 10.1016/j.abb.2004.04.020] [Cited by in Crossref: 129] [Cited by in F6Publishing: 131] [Article Influence: 7.2] [Reference Citation Analysis]
72 Schade AE, Levine AD. Signal transduction through the T cell receptor is dynamically regulated by balancing kinase and phosphatase activities. Biochemical and Biophysical Research Communications 2002;296:637-43. [DOI: 10.1016/s0006-291x(02)00925-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Yeh CM, Liu YC, Chang CJ, Lai SL, Hsiao CD, Lee SJ. Ptenb mediates gastrulation cell movements via Cdc42/AKT1 in zebrafish. PLoS One 2011;6:e18702. [PMID: 21494560 DOI: 10.1371/journal.pone.0018702] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
74 Schöndorf T, Dostal A, Grabmann J, Göhring U. Single Mutations of the PTEN Gene in Recurrent Ovarian Carcinomas. Journal of the Society for Gynecologic Investigation 2016;7:313-6. [DOI: 10.1177/107155760000700508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Chen W, Harris DL, Joyce NC. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells. Experimental Eye Research 2005;81:570-80. [DOI: 10.1016/j.exer.2005.03.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
76 Fan B, Luk AOY, Chan JCN, Ma RCW. MicroRNA and Diabetic Complications: A Clinical Perspective. Antioxidants & Redox Signaling 2018;29:1041-63. [DOI: 10.1089/ars.2017.7318] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
77 He L, Fan C, Gillis A, Feng X, Sanatani M, Hotte S, Kapoor A, Tang D. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. Biochim Biophys Acta 2007;1772:1134-42. [PMID: 17681738 DOI: 10.1016/j.bbadis.2007.07.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
78 Bian EB, Zhao B, Huang C, Wang H, Meng XM, Wu BM, Ma TT, Zhang L, Lv XW, Li J. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery. Cell Signal. 2013;25:1837-1844. [PMID: 23707524 DOI: 10.1016/j.cellsig.2013.05.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
79 Hlobilková A, Knillová J, Bártek J, Lukás J, Kolár Z. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:19-25. [PMID: 15034601 DOI: 10.5507/bp.2003.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
80 Shoman N, Klassen S, McFadden A, Bickis MG, Torlakovic E, Chibbar R. Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. Mod Pathol 2005;18:250-9. [PMID: 15475931 DOI: 10.1038/modpathol.3800296] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 5.4] [Reference Citation Analysis]
81 Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 2002;21:2357-2364. [PMID: 11948419 DOI: 10.1038/sj.onc.1205296] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
82 Zhu X, Qin X, Fei M, Hou W, Greshock J, Bachman KE, Kang J, Qin CY. Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma. Exp Ther Med 2013;5:57-64. [PMID: 23251242 DOI: 10.3892/etm.2012.749] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
83 Albert S, Serova M, Dreyer C, Sablin M, Faivre S, Raymond E. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer. Expert Opinion on Investigational Drugs 2010;19:919-30. [DOI: 10.1517/13543784.2010.499121] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
84 Zheng HC, Li YL, Sun JM, Yang XF, Li XH, Jiang WG, Zhang YC, Xin Y. Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products. World J Gastroenterol 2003; 9(8): 1662-1666 [PMID: 12918097 DOI: 10.3748/wjg.v9.i8.1662] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
85 He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet. 2004;36:1117-1121. [PMID: 15378062 DOI: 10.1038/ng1430] [Cited by in Crossref: 749] [Cited by in F6Publishing: 680] [Article Influence: 41.6] [Reference Citation Analysis]
86 Gu SH, Chen CH, Lin PL. Expression of protein tyrosine phosphatases and Bombyx embryonic development. J Insect Physiol 2021;130:104198. [PMID: 33549567 DOI: 10.1016/j.jinsphys.2021.104198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Cai T, Lei QY, Wang LY, Zha XL. TGF-beta 1 modulated the expression of alpha 5 beta 1 integrin and integrin-mediated signaling in human hepatocarcinoma cells. Biochem Biophys Res Commun. 2000;274:519-525. [PMID: 10913370 DOI: 10.1006/bbrc.2000.3177] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
88 Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J. PTEN: A crucial mediator of mitochondria-dependent apoptosis. Apoptosis 2006;11:197-207. [DOI: 10.1007/s10495-006-3714-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 5.6] [Reference Citation Analysis]
89 Miyata Y, Ashida S, Nakamura T, Mochizuki Y, Koga S, Kanetake H, Shuin T, Kanda S. Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo. Biochemical and Biophysical Research Communications 2003;302:892-7. [DOI: 10.1016/s0006-291x(03)00281-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Freeley M, Park J, Yang KJ, Wange RL, Volkov Y, Kelleher D, Long A. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells. Cell Signal 2007;19:2444-57. [PMID: 17826953 DOI: 10.1016/j.cellsig.2007.07.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
91 Crockett DK, Fillmore GC, Elenitoba-Johnson KS, Lim MS. Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. Proteomics 2005;5:1250-62. [PMID: 15717329 DOI: 10.1002/pmic.200401046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
92 Tan YS, Ooi KK, Ang KP, Akim AM, Cheah YK, Halim SN, Seng HL, Tiekink ER. Molecular mechanisms of apoptosis and cell selectivity of zinc dithiocarbamates functionalized with hydroxyethyl substituents. J Inorg Biochem 2015;150:48-62. [PMID: 26086852 DOI: 10.1016/j.jinorgbio.2015.06.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]